Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Salivary Alpha Amylase as a Biomarker of Transdermal Vagus Nerve Stimulation

NCT03854539 is registered in ClinicalTrials.gov with Arkansas Tech University as lead sponsor.

NCT NCT03854539
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03854539 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Salivary Alpha Amylase as a Biomarker of Transdermal Vagus Nerve Stimulation
Lead sponsor
Arkansas Tech University
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2018
Completion date
June 8, 2020
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

no condition salivary alpha amylase